As per MRFR analysis, the China Extracorporeal Membrane Oxygenation Machine Market Size was estimated at 105.6 (USD Million) in 2023. The China Extracorporeal Membrane Oxygenation Machine Market Industry is expected to grow from 111.6(USD Million) in 2024 to 257.1 (USD Million) by 2035. The China Extracorporeal Membrane Oxygenation Machine Market CAGR (growth rate) is expected to be around 7.882% during the forecast period (2025 - 2035).
The China Extracorporeal Membrane Oxygenation (ECMO) machine market is witnessing significant growth driven by several key market drivers. The increasing prevalence of respiratory and cardiac diseases, coupled with the rising incidence of severe COVID-19 cases, has created a pressing demand for advanced life-support machines. China's investment in healthcare infrastructure and technology is strengthening the availability and quality of medical devices, encouraging the adoption of ECMO machines across hospitals. Government initiatives to improve healthcare services are also propelling the ECMO market forward, as they create a more supportive environment for new technologies in medical treatments.
Opportunities are abundant in the Chinese market, particularly in the context of the modernisation of healthcare facilities and institutions. The increasing emphasis on the treatment of critical maladies through advanced medical technologies has opened up opportunities for manufacturers to establish partnerships with hospitals to provide advanced ECMO solutions. The future of this market can be influenced by the novel product launches that may result from the ongoing research and development investments in ECMO technology, which are designed to improve the efficacy of the device and the safety of the patient.
Furthermore, the provision of training to healthcare personnel in the use of ECMO machines can be a profitable sector for expansion, as it guarantees the efficient implementation of these devices in clinical environments. Recent trends suggest a trend towards ECMO machines that are more user-friendly and portable, with a focus on simplicity of use in critical care scenarios. Additionally, there is a growing trend of partnerships between domestic and international organisations in order to capitalise on the innovation potential of the ECMO sector, thereby enabling the exchange of knowledge and technology.
The standards of ECMO devices are being redefined by the continued emphasis on regulatory compliance and patient safety, ensuring that China is in accordance with global best practices in global healthcare. In general, the China ECMO market is defined by a combination of opportunities and robust demand drivers that are influencing its trajectory within the healthcare sector.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Increasing Incidence of Respiratory Diseases
The rising prevalence of respiratory diseases in China is a significant driver for the China Extracorporeal Membrane Oxygenation Machine Market. According to the Chinese National Health Commission, there has been a reported increase in chronic respiratory diseases, with approximately 1 million deaths attributed to chronic obstructive pulmonary disease in recent years.
This alarming statistic underscores a growing need for advanced medical equipment such as Extracorporeal Membrane Oxygenation machines.The increased investment by major hospitals and healthcare facilities in China, including partnerships with established organizations like China Medical Technology Corporation, is focused on enhancing patient care, leading to a robust demand for ECMO machines.
The Chinese government's continuous push for better healthcare infrastructure and technology further bolsters this trend, ensuring that the ECMO technology will play a crucial role in managing respiratory failures effectively.
Government Support for Healthcare Innovation
The Chinese government has been actively supporting healthcare innovation through various initiatives and policies aimed at improving medical technologies. The 'Healthy China 2030' initiative serves as a roadmap for reforming the health system and driving health technology advancements. Under this initiative, funding and incentives are provided for the Research and Development of life-saving medical devices, including Extracorporeal Membrane Oxygenation machines.
With the estimated increase in healthcare spending expected to reach 7.5% annually, as reported by the China National Development and Reform Commission, there is a conducive environment for ECMO manufacturers to thrive. The Chinese Ministry of Industry and Information Technology's push to foster innovation is likely to enhance the market landscape, further encouraging ECMO adoption across medical facilities in China.
Technological Advancements in Medical Equipment
Continuous advancements in medical technology play a pivotal role in propelling the China Extracorporeal Membrane Oxygenation Machine Market. Innovations such as portable ECMO systems and improved membranes for gas exchange efficiency have revolutionized patient care. In 2023, the China Food and Drug Administration approved multiple new ECMO devices that utilize cutting-edge technology, enhancing performance and patient outcomes. As healthcare providers in China increasingly recognize the benefits of such technology, investment in ECMO systems is expected to surge.
Organizations like the Chinese Society of Critical Care Medicine are also actively promoting education and awareness regarding ECMO technology, driving its application in hospitals throughout China. This combination of innovation and advocacy contributes significantly to the market growth.
The Application segment of the China Extracorporeal Membrane Oxygenation Machine Market consists of critical areas such as Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass, each contributing significantly to patient outcomes in acute medical scenarios. Cardiac Support has emerged as a crucial application, providing vital assistance in cases of heart failure or during cardiac surgery, thereby enhancing the survival rate and recovery period for patients. This area addresses the growing incidence of cardiovascular diseases in China, particularly in urban regions where lifestyle changes have impacted health.
Additionally, Respiratory Support has gained momentum, especially highlighted during recent global health crises, where ECMO machines played a pivotal role in managing severe respiratory failure cases. This application caters to patients with conditions such as severe pneumonia or acute respiratory distress syndrome, positioning itself as a key player in critical care settings. Furthermore, Cardiopulmonary Bypass is a vital application in cardiovascular surgeries, allowing surgeons to perform complex procedures by temporarily taking over the function of the heart and lungs.
The increasing number of surgical interventions in China, combined with advancements in technology, has reinforced the significance of this application, making it indispensable in modern medicine. Overall, the diverse applications within the China Extracorporeal Membrane Oxygenation Machine Market reflect evolving medical needs and advancements, fostering growth and innovation in the industry as healthcare delivery continues to improve in the region. The market is poised for ongoing developments driven by technological advancements, increasing patient populations, and the necessity for sophisticated cardiac and respiratory support solutions in China's healthcare infrastructure.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The China Extracorporeal Membrane Oxygenation Machine Market exhibits a diverse End User landscape, significantly influenced by the healthcare infrastructure and patient care dynamics within the country. Hospitals stand out as the primary adopter of Extracorporeal Membrane Oxygenation Machines due to their comprehensive capabilities in critical care and advanced surgical procedures. These institutions not only provide essential access to life-saving therapies, but they also serve as centers for training and research, fueled by ongoing advancements in medical technology.
Meanwhile, Ambulatory Surgical Centers have emerged as a growing segment, catering to patients who require less intensive interventions and promoting efficient use of medical resources. Their role in outpatient care reflects the trend towards providing high-quality healthcare services in more accessible settings. Additionally, Home Care Settings are becoming increasingly relevant, driven by the patient preference for treatment in familiar environments and the rising incidence of chronic diseases.
This segment’s growth illustrates the shift towards personalized healthcare responses, meeting the needs of patients requiring continuous monitoring and therapy outside traditional facilities.Overall, this segmentation underscores the evolving landscape of healthcare delivery in China, revealing opportunities for innovation and specialized services in response to patient demand.
The China Extracorporeal Membrane Oxygenation Machine Market exhibits a diverse array of product types, vital for addressing various clinical needs. Venoarterial ECMO plays a crucial role in providing support for patients experiencing cardiac and pulmonary failure, showcasing its significance in intensive care scenarios. Meanwhile, Venovenous ECMO is predominantly used for patients with severe respiratory issues, allowing for efficient oxygenation and carbon dioxide removal, highlighting its importance in respiratory therapies across hospitals. Arteriovenous ECMO serves as an alternative option, specifically in select cases where traditional methods may not be feasible.
Currently, the demand for these machine types is influenced by increasing incidences of respiratory and cardiac diseases, the growing aging population, and advancements in ECMO technologies. Furthermore, with efforts from the Chinese government to enhance healthcare infrastructure and encourage the adoption of advanced medical technologies, the product type segmentation within the China Extracorporeal Membrane Oxygenation Machine Market is anticipated to evolve, catering to the multifaceted healthcare requirements within the region.
The Component segment of the China Extracorporeal Membrane Oxygenation Machine Market plays a crucial role in enhancing the functionality and efficiency of these life-saving devices. Central to this segment is the Membrane Oxygenator, which serves as the core component responsible for gas exchange, making it indispensable for patients with cardiac and respiratory failure. Blood Pumps are equally significant as they facilitate blood circulation through the oxygenator, ensuring that oxygen-rich blood is delivered throughout the body. Heat Exchangers are essential for maintaining the optimal temperature of the blood during the oxygenation process, thereby preventing complications.
As the demand for advanced ECMO technology grows due to rising incidences of heart and lung diseases in China, these components are expected to see increased adoption and innovation. Additionally, government initiatives aimed at improving healthcare infrastructure and access to advanced medical devices further drive the need for robust and reliable components within this market. The emphasis on quality and reliability in these components correlates directly with patient outcomes, making them a focal point for manufacturers and healthcare providers alike.
China Extracorporeal Membrane Oxygenation Machine Market Key Players and Competitive Insights:
The China Extracorporeal Membrane Oxygenation Machine Market has witnessed significant growth due to the increasing incidence of cardiovascular diseases and respiratory failure among the population. This market is characterized by rapidly evolving technologies and an increasing number of players entering the field. The competition is intensifying as manufacturers strive to innovate and improve their product offerings through advanced technology integration, efficiency, and reliability. This rising demand for ECMO devices is coupled with enhanced healthcare investment in China, especially in critical care settings, further driving the growth and competition in this sector.
Companies that specialize in offering state-of-the-art ECMO solutions focus on building robust distribution networks, optimizing supply chains, and providing comprehensive customer support to establish a strong foothold in the market.Maquet has established itself as a key player within the China Extracorporeal Membrane Oxygenation Machine Market, known for its advanced ECMO technology and comprehensive solutions for healthcare facilities. The company's strength lies in its ability to provide reliable and high-performance machines that optimize oxygenation for patients in critical care. With a strong market presence, Maquet benefits from an extensive distribution network and partnerships with various hospitals, enabling it to reach a wide customer base.
The brand recognition and trust it has built over the years allow Maquet to maintain its competitive edge, as healthcare professionals prefer to work with established names that offer consistent quality and proven results.LivaNova has played a significant role in the China Extracorporeal Membrane Oxygenation Machine Market, bringing innovative solutions and key products designed to support cardiovascular health and critical clinical needs. The company’s market presence is strengthened by its commitment to advanced technology and development in ECMO systems, catering specifically to the needs of the Chinese healthcare sector.
LivaNova not only focuses on the core functionality of its products but also emphasizes comprehensive service provision, engaging healthcare professionals through training programs and support systems that ensure optimal use of their ECMO machines. In recent years, LivaNova has engaged in strategic mergers and acquisitions to enhance its capabilities and expand its reach in China, ultimately improving its product offerings and solidifying its position in the market. The combination of innovative technology, strong distribution channels, and a proactive approach to client engagement highlights LivaNova's strengths in this competitive landscape.
Key Companies in the China Extracorporeal Membrane Oxygenation Machine Market Include:
China Extracorporeal Membrane Oxygenation Machine Market Industry Developments
In recent developments, the China Extracorporeal Membrane Oxygenation (ECMO) Machine Market has seen significant advancements due to rising healthcare demands and improvements in medical technologies. Notable growth in market valuation is observed, particularly with key players such as Maquet and LivaNova increasing their production capabilities to meet the burgeoning demand driven by respiratory illnesses and critical care needs. On the mergers and acquisitions front, there have been no publicly reported activities by companies like Medtronic or Fresenius Medical Care in the last few months, indicating a potential focus on organic growth and product innovation.
Furthermore, the Chinese government has implemented policies to enhance medical infrastructure, fostering an environment conducive to the expansion of ECMO technology. In the last two to three years, from mid-2021 to 2023, China has increased investments in healthcare, thereby accelerating research and development initiatives among major players, including Pulmonx and Terumo. This has positioned the ECMO market in China on a growth trajectory, bolstered by technological advancements and a comprehensive approach to patient care services.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 105.6(USD Million) |
| MARKET SIZE 2024 | 111.6(USD Million) |
| MARKET SIZE 2035 | 257.1(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.882% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Maquet, LivaNova, Medtronic, Fresenius Medical Care, Pulmonx, Terumo, XENIOS AG, Abiomed, Nipro, Baxter International, Sorin Group, Getinge |
| SEGMENTS COVERED | Application, End User, Product Type, Component |
| KEY MARKET OPPORTUNITIES | Rising respiratory diseases, Increasing demand for organ transplants, Technological advancements in ECMO systems, Expanding healthcare infrastructure, Growing awareness among healthcare providers |
| KEY MARKET DYNAMICS | rising respiratory diseases, technological advancements in devices, increasing healthcare expenditure, government regulations and support, growing demand for organ transplant solutions |
| COUNTRIES COVERED | China |
Frequently Asked Questions (FAQ) :
The China Extracorporeal Membrane Oxygenation Machine Market is expected to be valued at 111.6 million USD in 2024.
By 2035, the market is expected to grow to 257.1 million USD.
The expected CAGR for the market from 2025 to 2035 is 7.882 percent.
The application for Respiratory Support is anticipated to hold a significant share, with a market value of 40.5 million USD in 2024.
The market for Cardiac Support is expected to increase from 36.5 million USD in 2024 to 84.1 million USD in 2035.
Major players include Maquet, LivaNova, Medtronic, and Fresenius Medical Care.
The Cardiopulmonary Bypass application is projected to reach a value of 78.8 million USD by 2035.
The market offers growth opportunities through advancements in technology and increased demand for cardiac and respiratory support applications.
Current global trends are shaping the market through innovations and increased healthcare investments in critical care solutions.
The respiratory support segment is expected to grow from 40.5 million USD in 2024 to 94.2 million USD in 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
